RhoVac AB announces, 6th February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition of Anne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, University of Bristol, UK.
February 6, 2020
· 2 min read